S&P 500   4,953.87 (-0.43%)
DOW   38,437.05 (-0.33%)
QQQ   423.66 (-0.86%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.87 (-0.43%)
DOW   38,437.05 (-0.33%)
QQQ   423.66 (-0.86%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.87 (-0.43%)
DOW   38,437.05 (-0.33%)
QQQ   423.66 (-0.86%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.87 (-0.43%)
DOW   38,437.05 (-0.33%)
QQQ   423.66 (-0.86%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
NASDAQ:NARI

Inari Medical (NARI) Stock Price, News & Analysis

$57.08
-1.03 (-1.77%)
(As of 02:21 PM ET)
Today's Range
$57.07
$58.04
50-Day Range
$55.88
$66.10
52-Week Range
$47.81
$71.85
Volume
164,837 shs
Average Volume
637,332 shs
Market Capitalization
$3.29 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$81.29

Inari Medical MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
42.4% Upside
$81.29 Price Target
Short Interest
Bearish
9.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.60mentions of Inari Medical in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$2.03 M Sold Last Quarter
Proj. Earnings Growth
Decreasing
From $0.06 to ($0.10) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.60 out of 5 stars

Medical Sector

683rd out of 932 stocks

Surgical & Medical Instruments Industry

77th out of 95 stocks


NARI stock logo

About Inari Medical Stock (NASDAQ:NARI)

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

NARI Stock Price History

NARI Stock News Headlines

5 medical stocks growing earnings by triple digits (NARI)
There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning
Inari Medical (NARI) to Release Quarterly Earnings on Wednesday
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
NARI Mar 2024 50.000 call
NARI Mar 2024 55.000 put
NARI Mar 2024 70.000 call
NARI Mar 2024 50.000 put
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Inari Medical Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Is Inari Medical (NARI) a Worthy Investment?
Inari Medical: Interesting Times
Inari Medical Moves Up Timeline for Profitability
Inari Medical Expects 22% Increase In Q4 Revenue
BTIG Reaffirms Their Buy Rating on Insulet (PODD)
Piper Sandler Keeps Their Buy Rating on Inari Medical (NARI)
BTIG Keeps Their Buy Rating on Inari Medical (NARI)
See More Headlines
Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2023
Today
2/21/2024
Next Earnings (Confirmed)
2/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NARI
Fax
N/A
Employees
1,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$81.29
High Stock Price Target
$100.00
Low Stock Price Target
$70.00
Potential Upside/Downside
+42.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-29,270,000.00
Pretax Margin
0.56%

Debt

Sales & Book Value

Annual Sales
$383.47 million
Book Value
$7.77 per share

Miscellaneous

Free Float
49,700,000
Market Cap
$3.29 billion
Optionable
Optionable
Beta
0.93
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives















NARI Stock Analysis - Frequently Asked Questions

Should I buy or sell Inari Medical stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NARI shares.
View NARI analyst ratings
or view top-rated stocks.

What is Inari Medical's stock price target for 2024?

6 brokers have issued 12 month target prices for Inari Medical's stock. Their NARI share price targets range from $70.00 to $100.00. On average, they predict the company's stock price to reach $81.29 in the next twelve months. This suggests a possible upside of 42.4% from the stock's current price.
View analysts price targets for NARI
or view top-rated stocks among Wall Street analysts.

How have NARI shares performed in 2024?

Inari Medical's stock was trading at $64.92 at the start of the year. Since then, NARI stock has decreased by 12.1% and is now trading at $57.08.
View the best growth stocks for 2024 here
.

Are investors shorting Inari Medical?

Inari Medical saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 4,920,000 shares, an increase of 11.6% from the January 15th total of 4,410,000 shares. Based on an average daily trading volume, of 679,800 shares, the short-interest ratio is currently 7.2 days. Currently, 10.0% of the company's stock are sold short.
View Inari Medical's Short Interest
.

When is Inari Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our NARI earnings forecast
.

How can I listen to Inari Medical's earnings call?

Inari Medical will be holding an earnings conference call on Wednesday, February 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Inari Medical's earnings last quarter?

Inari Medical, Inc. (NASDAQ:NARI) posted its earnings results on Wednesday, November, 1st. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.00 by $0.05. The firm had revenue of $126.37 million for the quarter, compared to analysts' expectations of $121.92 million. Inari Medical had a negative net margin of 0.59% and a negative trailing twelve-month return on equity of 0.64%. The business's revenue for the quarter was up 31.4% on a year-over-year basis. During the same period in the prior year, the company earned ($0.19) earnings per share.

What guidance has Inari Medical issued on next quarter's earnings?

Inari Medical issued an update on its FY 2023 earnings guidance on Tuesday, January, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $493.5 million-, compared to the consensus revenue estimate of $491.4 million.

What other stocks do shareholders of Inari Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY).

When did Inari Medical IPO?

(NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.

Who are Inari Medical's major shareholders?

Inari Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.75%), Franklin Resources Inc. (4.91%), Brown Advisory Inc. (2.96%), Voya Investment Management LLC (1.34%), Northern Trust Corp (1.12%) and Allspring Global Investments Holdings LLC (1.06%). Insiders that own company stock include Andrew Hykes, Ansbert Gadicke, Donald B Milder, Gilde Healthcare Cooperatieve, Kirk G Nielsen, Mitch C Hill, Mitch C Hill, Stanley Tang, Thomas Tu and William Hoffman.
View institutional ownership trends
.

How do I buy shares of Inari Medical?

Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NARI) was last updated on 2/21/2024 by MarketBeat.com Staff